The Japanese affiliate of GlaxoSmithKline, the world’s second-largest drug maker, failed to declare about 65 billion yen in income over a period of three years through its business year to Dec. 31, 2001, sources said Monday.

The Tokyo Regional Taxation Bureau reportedly found that Glaxo retained profits from stock sales at its affiliate in Singapore that should have been included in its taxable income, the sources said.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.